218 related articles for article (PubMed ID: 191203)
41. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
Chasin M; Harris DN
Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
[No Abstract] [Full Text] [Related]
42. Adenosine 3':5'-cyclic monophosphate phosphodiesterase activity in the dystrophic rat retina.
Dewar AJ; Barron G; Richmond J
Biochem Soc Trans; 1975; 3(2):265-8. PubMed ID: 165991
[No Abstract] [Full Text] [Related]
43. The stimulation of synaptosomal adenyl cyclase activity by the supernatant from rat brain cerebral cortex.
Izumi H; Ozawa H
Chem Pharm Bull (Tokyo); 1976 Apr; 24(4):555-9. PubMed ID: 949811
[No Abstract] [Full Text] [Related]
44. Possible regulation of membrane-associated cyclic AMP phosphodiesterase in rat cerebral cortex by lipids.
Baba A; Tsukamoto T; Matsuda T; Iwata H
Experientia; 1978 Sep; 34(9):1139-40. PubMed ID: 31295
[TBL] [Abstract][Full Text] [Related]
45. Effects of dopamine on kidney function and on the adenyl cyclase phosphodiesterase system in man.
Vlachoyannis J; Weismüller G; Schoeppe W
Eur J Clin Invest; 1976 Mar; 6(2):131-7. PubMed ID: 177293
[TBL] [Abstract][Full Text] [Related]
46. Regulation of intracellular cyclic AMP concentrations in hepatocytes involves the integrated activation and desensitization of adenylyl cyclase coupled with the action and activation of specific isoforms of cyclic AMP phosphodiesterase.
Houslay MD; Griffiths SL; Horton YM; Livingstone C; Lobban M; Macdonald F; Morris N; Pryde J; Scotland G; Shakur Y
Biochem Soc Trans; 1992 Feb; 20(1):140-6. PubMed ID: 1321746
[No Abstract] [Full Text] [Related]
47. [Effect of pituitary hormones on phosphodiesterase and adenyl cyclase activity of brain tissue in vitro].
Bulatov AA; Dzhaliashvili TA; Pankov IuA
Biull Eksp Biol Med; 1981 Apr; 91(4):429-31. PubMed ID: 6266549
[TBL] [Abstract][Full Text] [Related]
48. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
49. Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes.
Allende CC; Bravo R; Allende JE
J Biol Chem; 1977 Jul; 252(13):4662-6. PubMed ID: 194890
[No Abstract] [Full Text] [Related]
50. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
Green D; Guy G; Moore JB
Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
[No Abstract] [Full Text] [Related]
51. Cardiac adenylate cyclase, cyclic nucleotide phosphodiesterase and lactate dehydrogenase in normotensive and spontaneously hypertensive rats.
Hodgins DS; Frohlich ED
Biochem Pharmacol; 1978; 27(8):1179-85. PubMed ID: 212081
[No Abstract] [Full Text] [Related]
52. Calcium-dependent regulation of adenylate cyclase and phosphodiesterase activities in bovine lens: involvement of lens calmodulin.
Bizec JC; Klethi J; Mandel P
Exp Eye Res; 1985 Aug; 41(2):239-47. PubMed ID: 2998852
[TBL] [Abstract][Full Text] [Related]
53. [Adenyl cyclase and adenosine-3',5'-monophosphate phosphodiesteraze: their nature, properties and regulation].
Dumler IL; Etingof RN
Vopr Med Khim; 1976; 22(2):151-61. PubMed ID: 16391
[TBL] [Abstract][Full Text] [Related]
54. [The activity of 3',5'-AMP phosphodiesterase and inactivation of insulin during muscular activity].
Niiazmukhammedov MB; Iakovlev NN
Fiziol Zh SSSR Im I M Sechenova; 1976 May; 62(5):768-75. PubMed ID: 179902
[TBL] [Abstract][Full Text] [Related]
55. Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.
Ariano MA; Appleman MM
Brain Res; 1979 Nov; 177(2):301-9. PubMed ID: 227534
[TBL] [Abstract][Full Text] [Related]
56. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
57. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
Whalin ME; Garrett RL; Thompson WJ; Strada SJ
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
[TBL] [Abstract][Full Text] [Related]
58. Adenylate cyclase and cyclic nucleotide phosphodiesterases in the developing rat liver.
Sicard RE; Aprille JR
Biochim Biophys Acta; 1977 Dec; 500(2):235-45. PubMed ID: 201294
[No Abstract] [Full Text] [Related]
59. Changes of the activities of adenyl cyclase and cAMP-phosphodiesterase and of the level of 3'5' cyclic adenosine monophosphate in rat mammary gland during pregnancy and lactation.
Sapag-Hagar M; Greenbaum AL
Biochem Biophys Res Commun; 1973 Aug; 53(3):982-7. PubMed ID: 4354456
[No Abstract] [Full Text] [Related]
60. Hydrolytic rupture of ascorbate by adenosine 3':5'-cyclic monophosphate phosphodiesterase.
Lewin S
Biochem Soc Trans; 1976; 4(1):71-3. PubMed ID: 12036
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
